Build vs Buy: RPM Platform
Buy an off-the-shelf RPM platform if you need to launch a standard monitoring program in weeks and your workflows fit a vendor's mold. Build custom when RPM is your product or a core differentiator — proprietary device data, unusual clinical workflows, deep EHR write-back, or margins that can't absorb per-patient-per-month vendor fees at scale. Many teams do both: buy to validate fast, then build the parts that become strategic once volume and requirements are clear.
Quick answer
RPM is a feature you need now → buy. RPM is your product or your economics/workflows are non-standard → build. Validate with buy, then build what differentiates.
Decision table at a glance
| Criterion | Build | Buy |
|---|---|---|
| Time to launch | Months (quarters) | Weeks |
| Upfront cost | High (engineering) | Low (licensing/setup) |
| Cost at scale | Amortizes — you own it | Rises with per-patient fees |
| Control & roadmap | Full | Vendor-dependent |
| Customization | Unlimited | Within vendor limits |
| Data ownership | You own it | Shared / vendor-mediated |
| Maintenance burden | On you | On the vendor |
What they are
What is Build
Building means developing your own RPM platform — patient app, clinician dashboard, device integrations, alerting, and billing logic — on infrastructure you own. You control the roadmap, the data, the UX, and the unit economics, and you carry the engineering and compliance responsibility.
What is Buy
Buying means licensing a ready RPM platform (device kits, patient app, monitoring dashboard, billing support) and configuring it to your program. You trade control and margin for speed — a standard program can be live in weeks rather than quarters, with the vendor carrying device logistics and much of the compliance burden.
Key differences
Total cost of ownership crosses over
Buying is cheaper early — no build cost, predictable setup. But per-patient-per-month fees scale linearly with enrolled patients, while a custom build is a large fixed cost that amortizes. There's a crossover point (often a few thousand active patients, depending on vendor pricing) where building becomes cheaper per patient. Model your 3-year enrollment curve before deciding on cost alone.
Time to market and reimbursement
RPM reimbursement (CPT 99453/99454/99457/99458) rewards getting patients enrolled and monitored. Buying captures that revenue months sooner. If speed-to-reimbursement is the priority and workflows are standard, the buy option's velocity often outweighs its margin cost in the first year.
Control, differentiation, and IP
If RPM is how you win — unique device data, a superior patient experience, AI on longitudinal readings — a vendor platform commoditizes exactly what should set you apart. Building keeps the data, UX, and roadmap yours. If RPM is merely table stakes for a broader offering, that control isn't worth the build cost.
Compliance and device logistics
Vendors absorb a lot: FDA-cleared devices, shipping, PHI handling, and much of the HIPAA surface. Building means owning device sourcing/integration, PHI security, and audit-ready logging yourself. Factor the operational (not just software) cost of custom into the comparison.
When to use each
When to use Build (Custom)
- RPM is your core product or a genuine competitive differentiator.
- You need proprietary or unusual device integrations an off-the-shelf platform won't support.
- Per-patient-per-month vendor fees break your margins at your projected scale.
- You require deep, bidirectional EHR integration and workflow customization.
- You need to own the clinical and device data for analytics, AI, or IP reasons.
When to use Buy (Off-the-shelf)
- You need to launch a standard monitoring program quickly to capture reimbursement.
- Your workflows fit an existing vendor's model without heavy customization.
- You lack in-house engineering and compliance capacity to build and maintain a platform.
- You're validating an RPM line of business before committing capital to custom software.
- Patient volumes are modest enough that per-patient fees stay economical.
The hybrid path: buy now, build what matters
The strongest option is often sequenced, not either/or. Start on a vendor platform to launch fast, validate the clinical model, and begin capturing reimbursement. Learn where the vendor constrains you — the workflows, integrations, and data access that actually matter to your program.
Then build selectively: replace the pieces that became strategic (a differentiated patient app, proprietary device pipelines, deep EHR write-back, an analytics/AI layer on your own data) while keeping commodity pieces bought. This staged approach de-risks the build and times the fixed cost to when volume justifies it.
Frequently Asked Questions
Not sure which fits your build?
Tell us about your product, integration targets, and timeline. We'll map the trade-offs to your context and recommend the path that gets you to a compliant launch fastest.